EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiomics Integration Reveals KRT16 as a UPR‐Related Driver of Aggressive Tumor Behavior and Immunosuppression in Ovarian Serous Cystadenocarcinoma

Meng Yang, Peipei Zheng, Chan Meng, Weimin Wang

International Journal of Genomics · 2026-01 · 2026 (1)

DOI: 10.1155/ijog/4806618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 18.03.2026. Verfasst von Meng Yang und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian serous cystadenocarcinoma (OV) remains a lethal malignancy with complex tumor microenvironment (TME) dynamics and heterogeneous therapeutic responses. Unfolded protein response (UPR) signaling has been implicated in tumor progression and therapy resistance, yet its role in OV remains underexplored. Leveraging single‐cell RNA sequencing (scRNA‐seq) data and bulk RNA‐seq cohorts, we deciphered the cellular composition of the OV microenvironment and identified UPR‐related molecular subtypes. Through integrative analysis, we pinpointed KRT16 as a key prognostic gene associated with adverse outcomes. High KRT16 expression correlated with distinct mutational profiles, altered immune infiltration, and reduced sensitivity to targeted agents such as PD0325901 and dasatinib. Our findings nominate KRT16 as a novel biomarker and potential therapeutic target in OV, linking UPR activity to tumor aggression, cytoskeletal remodeling, immune modulation (including myeloid‐derived suppressor cell recruitment), and therapy resistance.

Zitieren

APA

Yang, M., Zheng, P., Meng, C., & Wang, W. (2026). Multiomics Integration Reveals KRT16 as a UPR‐Related Driver of Aggressive Tumor Behavior and Immunosuppression in Ovarian Serous Cystadenocarcinoma. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/4806618

Vancouver

Yang M, Zheng P, Meng C, Wang W. Multiomics Integration Reveals KRT16 as a UPR‐Related Driver of Aggressive Tumor Behavior and Immunosuppression in Ovarian Serous Cystadenocarcinoma. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/4806618

BibTeX
@article{Yang2026,
  author = {Yang, Meng and Zheng, Peipei and Meng, Chan and Wang, Weimin},
  title = {Multiomics Integration Reveals KRT16 as a UPR‐Related Driver of Aggressive Tumor Behavior and Immunosuppression in Ovarian Serous Cystadenocarcinoma},
  journal = {International Journal of Genomics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijog/4806618}
}
Kostenlos starten →